Retatrutide GLP-3 Pen 40mg

£150.00

Choose your bundle

Standard

1–2 Units

£150.00 / unit

No discount

✓

Save 5%

3–5 Units

£142.50 / unit

Total (×3): £427.50

✓

Best Value

6+ Units

£135.00 / unit

Total (×6): £810.00

✓

Free Shipping Over $175

99% PURE PEPTIDES

SAME DAY SHIPPING

Product Usage

Retatrutide GLP-3 Pen 40mg IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

Availability

Ships today if ordered and paid by 12 PM EST. (Except Saturdays & Sundays)

Shipping & Returns

Due to our rigorous quality control standards and the fragile nature of our products, we cannot accept returns. In the rare occasion that your order arrives with missing, incorrect or damaged items, please email info@purepeptides.io for assistance. Our customer support representatives are standing by to ensure that our customers are 100% satisfied with our product quality, customer support and delivery. Cancellations must be requested by email before the order shipment has shipped. Once the order has shipped you may not cancel your order. Please contact us at info@purepeptides.io with any questions or concerns that you may have regarding your order. We will do our absolute best to assist you as quickly and satisfactorily as possible.Thank you.

Retatrutide GLP-3

Price range: £40.00 through £220.00

Bacteriostatic Water 0.9% Benzyl Alcohol 10mL – Hospira Injection USP

£15.00

AOD 9604 5mg

£45.00

A pre-filled research glp-3 pen containing 40 mg of retatrutide, an investigational unimolecular triple agonist designed to engage three metabolic receptors at once: GLP-1, GIP, and glucagon. Unlike single-pathway GLP-1 compounds or dual GIP/GLP-1 agonists, retatrutide was engineered to coordinate several parts of energy balance in one molecule.

GLP-1 receptor activity is associated with reduced appetite and slower gastric emptying. GIP receptor activity supports insulin signaling and complementary effects on adipose tissue. Glucagon receptor activity adds a third axis: increased energy expenditure, hepatic fat oxidation, and a shift toward greater calorie use rather than intake reduction alone.

The peptide is built on a modified incretin backbone with structural changes that improve stability and extend circulating time through albumin binding. In published research, this profile has been studied as a once-weekly subcutaneous compound with a multi-day half-life. The 40 mg pen presents the full labeled content in a ready-to-use format, so researchers can work with measured click-based aliquots instead of reconstituting lyophilized powder for each protocol.

Disclaimer:

For laboratory and in vitro research use only. Not for human or veterinary use, consumption, diagnostic procedures, or therapeutic application. 40 mg refers to the total peptide content of the pen, not a recommended dose. Retatrutide is an investigational compound and is not an approved finished medicine. Handle in accordance with applicable research regulations and institutional protocols.